Literature DB >> 11573132

Iodide handling by the thyroid epithelial cell.

M Nilsson1.   

Abstract

Iodination of thyroglobulin, the key event in the synthesis of thyroid hormone, is an extracellular process that takes place inside the thyroid follicles at the apical membrane surface that faces the follicular lumen. The supply of iodide involves two steps of TSH-regulated transport, basolateral uptake and apical efflux, that imprint the polarized phenotype of the thyroid cell. Iodide uptake is generated by the sodium/iodide symporter present in the basolateral plasma membrane. A candidate for the apical iodide-permeating mechanism is pendrin, a chloride/iodide transporting protein recently identified in the apical membrane. In physiological conditions, transepithelial iodide transport occurs without intracellular iodination, despite the presence of large amounts of thyroglobulin and thyroperoxidase inside the cells. The reason is that hydrogen peroxide, serving as electron acceptor in iodide-protein binding and normally produced at the apical cell surface, is rapidly degraded by cytosolic glutathione peroxidase once it enters the cells. Iodinated thyroglobulin in the lumen stores not only thyroid hormone but iodine incorporated in iodotyrosine residues as well. After endocytic uptake and degradation of thyroglobulin, intracellular deiodination provides a mechanism for recycling of iodide to participate in the synthesis of new thyroid hormone at the apical cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573132     DOI: 10.1055/s-2001-11014

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  15 in total

1.  Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing.

Authors:  David A Kleiman; Daniel Buitrago; Michael J Crowley; Toni Beninato; Alexander J Veach; Pat B Zanzonico; Moonsoo Jin; Thomas J Fahey; Rasa Zarnegar
Journal:  J Surg Res       Date:  2012-09-08       Impact factor: 2.192

2.  TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells.

Authors:  Liuska Pesce; Aigerim Bizhanova; Juan Carlos Caraballo; Whitney Westphal; Maria L Butti; Alejandro Comellas; Peter Kopp
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

3.  Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status.

Authors:  Mosin S Khan; Arshad A Pandith; Shariq R Masoodi; Khursheed A Wani; Mahboob Ul Hussain; Syed Mudassar
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

4.  Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Authors:  Peng Hou; Ermal Bojdani; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2009-12-11       Impact factor: 5.958

5.  Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.

Authors:  Peng Hou; Dingxie Liu; Meiju Ji; Zhi Liu; James M Engles; Richard L Wahl; Mingzhao Xing
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

Review 6.  Prognostic utility of BRAF mutation in papillary thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

Review 7.  Recent advances in molecular biology of thyroid cancer and their clinical implications.

Authors:  Mingzhao Xing
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

8.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

9.  The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma.

Authors:  Roy Moncayo; Alexander Kroiss; Manfred Oberwinkler; Fatih Karakolcu; Matthias Starzinger; Klaus Kapelari; Heribert Talasz; Helga Moncayo
Journal:  BMC Endocr Disord       Date:  2008-01-25       Impact factor: 2.763

10.  Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells.

Authors:  Huan-Jun Wang; Jin-Ming Yao; Zhong-Wen Zhang; Jun-Yu Zhao; Hong-Xia Shang; Lin Liao; Jian-Jun Dong
Journal:  Thorac Cancer       Date:  2015-07-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.